Oxford Investments Holdings Inc.
Oxford Investments Holdings Inc.
Your view on OXIHF
Overview
What the company does, where it operates, and who runs it.
About Oxford Investments Holdings Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Michael Donaghy
- Headquarters
- 1315 Lawrence Avenue East, Toronto, ON, CA
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Michael Donaghy
- Headquarters
- 1315 Lawrence Avenue East, Toronto, ON, CA
Oxford Investments Holdings Inc., together with its subsidiaries, engages in the business of direct-banking and payment-card solutions. The company offers 'FocusKard' suite of products that consists of an online-access account represented by a stored-value card, which is a substitute for cash, gift certificates, and check payments.
Its stored-value card's applications include payroll, gift-card, travel, insurance, membership, student, and incentive/promotional products. The company was formerly known as Oxford Software Developers Inc. and changed its name to Oxford Investments Holdings Inc. in December 2003.
Oxford Investments Holdings Inc. was founded in 2000 and is headquartered in Toronto, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Oxford Investments Holdings Inc., and the rating behind it. OXIHF last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Oxford Investments Holdings Inc.. Starting points for Oxford Investments Holdings Inc.: beta 0.27 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Oxford Investments Holdings Inc.. Oxford Investments Holdings Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Oxford Investments Holdings Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Oxford Investments Holdings Inc.. Oxford Investments Holdings Inc. has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Oxford Investments Holdings Inc. valued side by side against its closest peers. Oxford Investments Holdings Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Oxford Investments Holdings Inc., and how their positions are changing. At a $71,958 market value, institutional positions materially move Oxford Investments Holdings Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Oxford Investments Holdings Inc. executives and directors. Shares of Oxford Investments Holdings Inc. have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Oxford Investments Holdings Inc.. Oxford Investments Holdings Inc. is a $71,958 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Oxford Investments Holdings Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Oxford Investments Holdings Inc.. Coverage tracks Oxford Investments Holdings Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.